Drug Profile
PSK 3841
Alternative Names: HMR 3841; RU 58841Latest Information Update: 04 Feb 2011
Price :
$50
*
At a glance
- Originator ProStrakan
- Class Antiacnes; Antiandrogens; Benzonitrile; Imidazolidines; Small molecules
- Mechanism of Action Testosterone congener inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acne; Alopecia
Most Recent Events
- 31 May 2007 No development reported - Phase-I for Acne in USA (Topical)
- 31 May 2007 No development reported - Phase-I for Alopecia in USA (Topical)
- 22 Sep 2004 ProSkelia has merged with Strakan to form ProStrakan